Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient.
Basara
N
N
Clinic for Bone Marrow Transplantation and Hematology/Oncology, Idar-Oberstein, Germany.
Blau
W I
WI
Kiehl
M G
MG
Römer
E
E
Rudolphi
M
M
Bischoff
M
M
Kirsten
D
D
Sanchez
H
H
Günzelmann
S
S
Fauser
A A
AA
D000208:Acute Disease; D016026:Bone Marrow Transplantation / Q000276:immunology*; D002908:Chronic Disease; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006086:Graft vs Host Disease / Q000188:drug therapy* / Q000517:prevention & control; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007938:Leukemia / Q000628:therapy*; D019520:Living Donors; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009679:Nuclear Family; D011239:Prednisolone / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D009173:Mycophenolic Acid